Phillip R. Pittman

2.8k citations

54 papers · 1.9k indexed · h-index 24

Virology top 1%
- Poxvirus research and outbreaks 21
Infectious Diseases top 1%
- Viral Infections and Outbreaks Research 21
- Viral Infections and Vectors 15
- SARS-CoV-2 and COVID-19 Research 9
Public Health, Environmental and Occupational Health top 5%
- Mosquito-borne diseases and control 9
Molecular Biology top 10%
- Bacillus and Francisella bacterial research 30
Epidemiology top 10%
- Virology and Viral Diseases 6
Ecology, Evolution, Behavior and Systematics
- Vector-Borne Animal Diseases 6

Co-authors: Paul Gibbs Arthur M. Friedlander Timothy Lewis Cannon Joseph A. Mangiafico Gerald W. Parker C. J. Peters Richard S. Makuch Richard E. McCarty
Cited by: Virology Infectious Diseases Public Health, Environmental and Occupational Health
Journals: New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)JAMA (1 paper)
Partner nations: United States South Korea Democratic Republic of the Congo

In The Last Decade

Phillip R. Pittman

52 papers receiving 1.8k citations

Peers

Countries citing papers authored by Phillip R. Pittman

Since Specialization

Citations

This map shows the geographic impact of Phillip R. Pittman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip R. Pittman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip R. Pittman more than expected).

Fields of papers citing papers by Phillip R. Pittman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip R. Pittman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip R. Pittman. The network helps show where Phillip R. Pittman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Phillip R. Pittman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Phillip R. Pittman Line = papers co-authored together Phillip R. Pittman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Modeling lesion transition dynamics to clinically characterize patients with clade I mpox in the Democratic Republic of the Congo Science Translational Medicine ·Takara Nishiyama,Fuminari Miura,Yong Dam Jeong,Naotoshi Nakamura,Hyeongki Park,Masahiro Ishikane,Shotaro Yamamoto,Noriko Iwamoto,Michiyo Suzuki,Ayana Sakurai,Kazuyuki Aihara,Koichi Watashi,William S. Hart,Robin N. Thompson,Yasuhiro Yasutomi,Norio Ohmagari,Placide Mbala Kingebeni,John W. Huggins,Shingo Iwami,Phillip R. Pittman	2025	0
2	Mpox Virus in Pregnancy, the Placenta, and Newborn Archives of Pathology & Laboratory Medicine ·David A. Schwartz,Sandy Ha,Pradip Dashraath,David Baud,Phillip R. Pittman,Kristina M. Adams Waldorf	2023	21
3	Mpox (Monkeypox) in Pregnancy: Viral Clade Differences and Their Associations with Varying Obstetrical and Fetal Outcomes Viruses ·David A. Schwartz,Phillip R. Pittman	2023	19
4	The O-Ag Antibody Response to Francisella Is Distinct in Rodents and Higher Animals and Can Serve as a Correlate of Protection Pathogens ·Lauren E. Shoudy,Prachi Namjoshi,Gabriela F. Giordano,Sudeep Kumar,Jennifer D. Bowling,H. Carl Gelhaus,Eileen M. Barry,Allan J. Hazlett,Brian A. Hazlett,Kristine Cooper,Phillip R. Pittman,Douglas S. Reed,Karsten R. O. Hazlett	2021	3
5	Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition Proceedings of the National Academy of Sciences ·Nathaniel S. Chapman,Haiyan Zhao,Nurgun Kose,Jonna B. Westover,Birte Kalveram,Robin Bombardi,Jessica Rodríguez,Rachel E. Sutton,Joseph R. Genualdi,A. Desirée LaBeaud,Francis Mutuku,Phillip R. Pittman,Alexander N. Freiberg,Brian B. Gowen,Daved H. Fremont,James E. Crowe	2021	23
6	Povidone Iodine Ointment Application to the Vaccination Site Does Not Alter Immunoglobulin G Antibody Response to Smallpox Vaccine Viral Immunology ·Christine Pugh,Elizabeth S. Brown,Xiaofei Quinn,Lawrence Korman,Beverly K. Dyas,Robert G. Ulrich,Phillip R. Pittman	2016	0
7	Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response Vaccine ·Phillip R. Pittman,Patrick M. Garman,Sung‐Han Kim,Trevor J Schmader,William J Nieding,Jason G. PIKE,Ryan Knight,Sara C. Johnston,John W. Huggins,Mark G. Kortepeter,Lawrence Korman,Manmohan V. Ranadive,Xiaofei Quinn,Mitchell S Meyers	2015	10
8	Anthrax vaccine adsorbed: Further evidence supporting continuing the vaccination series rather than restarting the series when doses are delayed Vaccine ·Phillip R. Pittman,M.A. Cavicchia,John Kingsbury,Natasha Johnson,Julio Barrera-Oro,Trevor J Schmader,Lawrence Korman,Xiaofei Quinn,Manmohan V. Ranadive	2014	5
9	Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study Vaccine ·Janice M. Rusnak,Paul Gibbs,Ellen F. Boudreau,Denise P. Clizbe,Phillip R. Pittman	2011	34
10	Th17 Cytokines in Recall Responses Against Francisella Tularensis in Humans Journal of Interferon & Cytokine Research ·Chrysanthi Paranavitana,E Zelazowska,Luis DaSilva,Phillip R. Pittman,Mikeljon P. Nikolich	2010	19
11	Transcriptional profiling ofFrancisella tularensisinfected peripheral blood mononuclear cells: a predictive tool for tularemia FEMS Immunology & Medical Microbiology ·Chrysanthi Paranavitana,Phillip R. Pittman,Mahendran Velauthapillai,E Zelazowska,Luis L. P. daSilva	2008	20
12	Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea Antiviral Research ·Janice M. Rusnak,W. Russell Byrne,Kyung N. Chung,Paul Gibbs,Theodore T. Kim,Ellen F. Boudreau,Thomas M. Cosgriff,Phillip R. Pittman,Katie Y. Kim,Marianne S. Erlichman,David F. Rezvani,John W. Huggins	2008	69
13	Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series☆ Vaccine ·Phillip R. Pittman,Sarah L. Norris,Julio Barrera-Oro,David M. Bedwell,Timothy Lewis Cannon,K MCKEEJR	2006	37
14	Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine Vaccine ·Matthew J. Hepburn,Mark G. Kortepeter,Phillip R. Pittman,Ellen F. Boudreau,Joseph A. Mangiafico,P Buck,Sarah L. Norris,E. L. Anderson	2006	42
15	Long-term health effects of repeated exposure to multiple vaccines Vaccine ·Phillip R. Pittman,Kevin Coonan,Peter Gibbs,Hayley A. Scott,Timothy Lewis Cannon,K MCKEEJR	2004	11
16	Analysis of Adverse Events after Anthrax Immunization in US Army Medical Personnel Journal of Occupational and Environmental Medicine ·Glenn M. Wasserman,John D. Grabenstein,Phillip R. Pittman,Mark V. Rubertone,Paul P. Gibbs,Linda Z. Wang,Lance G. Golder	2003	47
17	Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans Vaccine ·Phillip R. Pittman,Gina Kim-Ahn,Dominique Pifat,Kevin Coonan,Paul Gibbs,S F Little,Judith G. Pace-Templeton,Robert A. Myers,Gerald W. Parker,Arthur M. Friedlander	2002	107
18	Anthrax vaccine: short-term safety experience in humans Vaccine ·Phillip R. Pittman,Paul Gibbs,Timothy Lewis Cannon,Arthur M. Friedlander	2001	91
19	Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humans Vaccine ·Phillip R. Pittman,Joseph A. Mangiafico,Cynthia A. Rossi,Timothy Lewis Cannon,Paul Gibbs,Gerald W. Parker,Arthur M. Friedlander	2000	45
20	Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine Vaccine ·Phillip R. Pittman,Richard S. Makuch,Joseph A. Mangiafico,Timothy Lewis Cannon,Paul Gibbs,C. J. Peters	1996	165

About Phillip R. Pittman

Phillip R. Pittman is a scholar working on Virology, Infectious Diseases and Chemical Health and Safety, having authored 54 papers that have together received 1.9k indexed citations. Recurring topics across this work include Bacillus and Francisella bacterial research (30 papers), Viral Infections and Outbreaks Research (21 papers), Poxvirus research and outbreaks (21 papers), Viral Infections and Vectors (15 papers), SARS-CoV-2 and COVID-19 Research (9 papers), Mosquito-borne diseases and control (9 papers), Virology and Viral Diseases (6 papers) and Vector-Borne Animal Diseases (6 papers). The work is most often cited by research in Virology (436 citations), Infectious Diseases (1.0k citations) and Public Health, Environmental and Occupational Health (447 citations). Phillip R. Pittman has collaborated with scholars based in United States, South Korea and Democratic Republic of the Congo. Frequent co-authors include Paul Gibbs, Arthur M. Friedlander, Timothy Lewis Cannon, Joseph A. Mangiafico, Gerald W. Parker, C. J. Peters, Richard S. Makuch, Richard E. McCarty, Yoko Tsuchiya and Sarah L. Norris. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact